强心药在心力衰竭应用中的再评价

摘要

Cardiotonic drugs are divided into two categories of digitalis and non-digitalis drugs.Cardiotonic drugs have been used as the first choice drugs in the treatment of heart failure for more than 200 years.However,their evidence for long-term prognosis is not sufficient.Many clinical trials and post hoc analysis of the long-term efficacy of cardiotonic drugs to evaluate,the results are controversial.Due to the lack of evidence-based support,cardiotonic drugs have been used as the final choice in the treatment of heart failure.%强心药分为洋地黄和非洋地黄药物两类,在200余年的心力衰竭治疗过程中,强心药曾经被作为首选药物,但其对于远期预后影响的循证医学证据不够充分,许多临床试验及事后分析对强心药的远期疗效进行评价,结果颇具争议.由于缺乏循证医学证据的支持,目前强心药物已做为心力衰竭治疗中的最后选择.